About Life Sciences Key Technologies

LSK Technologies provides a low-cost diagnostic platform that utilizes nucleic acid testing and advanced camera vision technology to deliver results for COVID-19 and other diseases within 30 minutes. This solution enables high-throughput testing with real-time result access, addressing the need for rapid and affordable diagnostics in various healthcare settings.

```xml <problem> Traditional laboratory-based nucleic acid testing for viral and antibody detection often requires specialized equipment, trained personnel, and complex logistics, leading to delays and increased costs. This can limit access to rapid and accurate diagnostics, particularly in point-of-care settings like pharmacies and remote locations. </problem> <solution> LSK Technologies offers a low-cost, high-throughput diagnostic platform that enables rapid nucleic acid testing for various diseases, including COVID-19. The platform combines advanced camera vision technology with molecular kits to quantitatively analyze optical reactions, delivering results in approximately 30 minutes. This solution provides real-time access to results and simplifies logistics, making lab-quality testing accessible in diverse settings. The platform is available in configurations suited for both laboratory and pharmacy environments, offering scalable solutions for viral and antibody detection. </solution> <features> - High-throughput plate reader for viral and antibody detection in a multimode format - Molecular kits optimized for use with the plate reader - Scalable plug-and-play testing solution designed for pharmacy settings - PCR-equivalent test results at the speed of an antigen test - Advanced camera vision technology for quantitative analysis of optical reactions - Real-time access to test results </features> <target_audience> The primary target audiences include laboratories seeking high-throughput viral and antibody detection, as well as pharmacies looking for scalable, point-of-care testing solutions. </target_audience> ```

What does Life Sciences Key Technologies do?

Where is Life Sciences Key Technologies located?

Life Sciences Key Technologies is based in Kitchener, Canada.

When was Life Sciences Key Technologies founded?

Life Sciences Key Technologies was founded in 2019.

How much funding has Life Sciences Key Technologies raised?

Life Sciences Key Technologies has raised 199703.

Location

Kitchener, Canada

Founded

2019

Funding

199703

Employees

2 employees

Major Investors

Y Combinator, Velocity, Front Row Ventures, UTEST

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Life Sciences Key Technologies

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

lifesci-key.com 500+

Crunchbase

Founded 2019 – Kitchener, Canada

Funding

Estimated Funding

$100K+

Major Investors

Y Combinator, Velocity, Front Row Ventures, UTEST

Team (<5)

No team information available.

Company Description

Problem

Traditional laboratory-based nucleic acid testing for viral and antibody detection often requires specialized equipment, trained personnel, and complex logistics, leading to delays and increased costs. This can limit access to rapid and accurate diagnostics, particularly in point-of-care settings like pharmacies and remote locations.

Solution

LSK Technologies offers a low-cost, high-throughput diagnostic platform that enables rapid nucleic acid testing for various diseases, including COVID-19. The platform combines advanced camera vision technology with molecular kits to quantitatively analyze optical reactions, delivering results in approximately 30 minutes. This solution provides real-time access to results and simplifies logistics, making lab-quality testing accessible in diverse settings. The platform is available in configurations suited for both laboratory and pharmacy environments, offering scalable solutions for viral and antibody detection.

Features

High-throughput plate reader for viral and antibody detection in a multimode format

Molecular kits optimized for use with the plate reader

Scalable plug-and-play testing solution designed for pharmacy settings

PCR-equivalent test results at the speed of an antigen test

Advanced camera vision technology for quantitative analysis of optical reactions

Real-time access to test results

Target Audience

The primary target audiences include laboratories seeking high-throughput viral and antibody detection, as well as pharmacies looking for scalable, point-of-care testing solutions.